These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23732755)

  • 1. Depression, psychological distress, and quality of life in patients with cardioverter defibrillator with or without cardiac resynchronization therapy.
    Knackstedt C; Arndt M; Mischke K; Marx N; Nieman F; Kunert HJ; Schauerte P; Norra C
    Heart Vessels; 2014 May; 29(3):364-74. PubMed ID: 23732755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cardiac resynchronization therapy and implantable cardioverter defibrillator on quality of life in patients with heart failure: a meta-analysis.
    Chen S; Yin Y; Krucoff MW
    Europace; 2012 Nov; 14(11):1602-7. PubMed ID: 23104857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
    Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch Block: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy.
    Biton Y; Kutyifa V; Cygankiewicz I; Goldenberg I; Klein H; McNitt S; Polonsky B; Ruwald AC; Ruwald MH; Moss AJ; Zareba W
    Circ Heart Fail; 2016 Feb; 9(2):e002667. PubMed ID: 26823498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart-focused anxiety in patients with chronic heart failure before implantation of an implantable cardioverter defibrillator: baseline findings of the Anxiety-CHF Study.
    Bunz M; Lenski D; Wedegärtner S; Ukena C; Karbach J; Böhm M; Kindermann I
    Clin Res Cardiol; 2016 Mar; 105(3):216-24. PubMed ID: 26481915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventricular Electrical Delay Measured From Body Surface ECGs Is Associated With Cardiac Resynchronization Therapy Response in Left Bundle Branch Block Patients From the MADIT-CRT Trial (Multicenter Automatic Defibrillator Implantation-Cardiac Resynchronization Therapy).
    Plesinger F; Jurak P; Halamek J; Nejedly P; Leinveber P; Viscor I; Vondra V; McNitt S; Polonsky B; Moss AJ; Zareba W; Couderc JP
    Circ Arrhythm Electrophysiol; 2018 May; 11(5):e005719. PubMed ID: 29700054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT.
    Perkiomaki JS; Ruwald AC; Kutyifa V; Ruwald MH; Mcnitt S; Polonsky B; Goldstein RE; Haigney MC; Krone RJ; Zareba W; Moss AJ;
    Europace; 2015 Dec; 17(12):1816-22. PubMed ID: 26071234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poor health status and distress in cardiac patients: the role of device therapy vs. underlying heart disease.
    Habibović M; Versteeg H; Pelle AJ; Theuns DA; Jordaens L; Pedersen SS
    Europace; 2013 Mar; 15(3):355-61. PubMed ID: 22989939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced long-term overall mortality in heart failure patients with prolonged QRS treated with CRT combined with ICD vs. heart failure patients with narrow QRS treated with ICD only.
    Palmisano P; Accogli M; Pisanò EC; Zaccaria M; De Blasi S; Ponzetta MA; Valsecchi S; Milanese G; Lauretti M; Magliari F
    Europace; 2016 Sep; 18(9):1374-82. PubMed ID: 26612878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
    Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF;
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Super-response to cardiac resynchronization therapy reduces appropriate implantable cardioverter defibrillator therapy.
    Killu AM; Mazo A; Grupper A; Madhavan M; Webster T; Brooke KL; Hodge DO; Asirvatham SJ; Friedman PA; Glikson M; Cha YM
    Europace; 2018 Aug; 20(8):1303-1311. PubMed ID: 29016821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and safety of cardiac resynchronization therapy combined with implantable cardioverter defibrillator for heart failure: a meta-analysis of 5674 patients.
    Chen S; Ling Z; Kiuchi MG; Yin Y; Krucoff MW
    Europace; 2013 Jul; 15(7):992-1001. PubMed ID: 23419662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PR interval identifies clinical response in patients with non-left bundle branch block: a Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy substudy.
    Kutyifa V; Stockburger M; Daubert JP; Holmqvist F; Olshansky B; Schuger C; Klein H; Goldenberg I; Brenyo A; McNitt S; Merkely B; Zareba W; Moss AJ
    Circ Arrhythm Electrophysiol; 2014 Aug; 7(4):645-51. PubMed ID: 24963007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac resynchronization and quality of life in patients with minimally symptomatic heart failure.
    Veazie PJ; Noyes K; Li Q; Hall WJ; Buttaccio A; Thevenet-Morrison K; Moss AJ
    J Am Coll Cardiol; 2012 Nov; 60(19):1940-4. PubMed ID: 23062542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT).
    Healey JS; Hohnloser SH; Exner DV; Birnie DH; Parkash R; Connolly SJ; Krahn AD; Simpson CS; Thibault B; Basta M; Philippon F; Dorian P; Nair GM; Sivakumaran S; Yetisir E; Wells GA; Tang AS;
    Circ Heart Fail; 2012 Sep; 5(5):566-70. PubMed ID: 22896584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator.
    Martens P; Verbrugge FH; Nijst P; Dupont M; Nuyens D; Herendael HV; Rivero-Ayerza M; Tang WH; Mullens W
    Heart; 2017 Dec; 103(24):1977-1984. PubMed ID: 28716973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and risk markers of early psychological distress after ICD implantation in the European REMOTE-CIED study cohort.
    Versteeg H; Timmermans I; Meine M; Zitron E; Mabo P; Denollet J
    Int J Cardiol; 2017 Aug; 240():208-213. PubMed ID: 28389124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications in recipients of cardioverter-defibrillator or cardiac resynchronization therapy: Insights from Silesian Center Defibrillator registry.
    Tajstra M; Gadula-Gacek E; Kurek A; Adamowicz-Czoch E; Olszowski D; Ostręga M; Ciślak A; Pyka Ł; Hawranek M; Lekston A; Poloński L; Gąsior M
    Cardiol J; 2017; 24(5):515-522. PubMed ID: 27734455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amiodarone is associated with adverse outcomes in patients with sustained ventricular arrhythmias upgraded to cardiac resynchronization therapy-defibrillators.
    Adelstein EC; Althouse AD; Davis L; Schwartzman D; Bazaz R; Jain S; Wang N; Saba S
    J Cardiovasc Electrophysiol; 2019 Mar; 30(3):348-356. PubMed ID: 30575185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome in patients undergoing upgrade to cardiac resynchronization therapy: predictors of outcome after upgrade to CRT.
    Kosiuk J; Krause M; Doering M; Weber A; Breithardt OA; Dinov B; Darma A; Lucas J; Muessigbrodt A; Bode K; Kuehl M; Dagres N; Hindricks G; Bollmann A; Richter S
    Heart Vessels; 2020 Jan; 35(1):104-109. PubMed ID: 31227877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.